Abstracts tagged "morbidity and mortality"

Abstract Number: 290 • 2012 ACR/ARHP Annual Meeting
Long-Term Outcomes in Neonatal Lupus
Amit Saxena¹, Peter M. Izmirly², Deborah Friedman³ and Jill P. Buyon⁴, ¹Medicine, New York University School of Medicine, New York, NY, ²Medicine, Division of Rheumatology, NYU School of Medicine, New York, NY, ³Division of Pediatric Cardiology, New York Medical College, Valhalla, NY, ⁴Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY
Background/Purpose: Several studies have evaluated mortality and short-term morbidity in neonatal lupus (NL), however there have been no substantive descriptions of the long term cardiac,…
Abstract Number: 698 • 2012 ACR/ARHP Annual Meeting
External Validation of a Two-Year Mortality Risk Prediction Rule in Early Diffuse Systemic Sclerosis Patients
Robyn T. Domsic¹, Svetlana Nihtyanova², Stephen R. Wisniewski³, Michael J. Fine⁴, C. Kent Kwoh⁵, Christopher P. Denton⁶ and Thomas A. Medsger Jr.⁷, ¹Medicine - Rheumatology, University of Pittsburgh, Pittsburgh, PA, ²Department of Rheumatology, Royal Free Hospital, Medical School, London, England, ³Epidemiology, University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA, ⁴General Medicine, University of Pittsburgh and Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare, Pittsburgh, PA, ⁵School of Medicine, Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, ⁶Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School, London, United Kingdom, ⁷Medicine/Rheumatology, Univ of Pittsburgh, Pittsburgh, PA
Background/Purpose: The ability to risk stratify patients for short term mortality is important in SSc patient care and clinical trial design; but there is…
Abstract Number: 697 • 2012 ACR/ARHP Annual Meeting
Demographic, Clinical, Serologic and Socioeconomic Measures Each Predict Mortality in Scleroderma
Allan C. Gelber¹, Rebecca L. Manno², Adrianne Woods¹, Ami A. Shah³, Francesco Boin³, Laura K. Hummers³ and Fredrick M. Wigley³, ¹Medicine/ Rheumatology, Johns Hopkins University, Baltimore, MD, ²Division of Rheumatology, Johns Hopkins University, Baltimore, MD, ³Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD
Multivariate Model 1 Adjusted RR 95%CI Multivariate Model 2 Adjusted RR 95%CI Male vs Female 1.4 1.1 – 1.9 Male vs Female 1,4…
Abstract Number: 696 • 2012 ACR/ARHP Annual Meeting
Risk Factors for EARLY Mortality in Scleroderma Patients: A Report From the EULAR Scleroderma Trials and Research Group (EUSTAR) Database
Patricia E. Carreira¹, Loreto Carmona², Beatriz E. Joven³, Christopher P. Denton⁴, Yannick Allanore⁵, Ulrich A. Walker⁶, Marco Matucci-Cerinic⁷, Ulf Müller-Ladner⁸ and Eustar⁹, ¹Rheumatology, Hospital Universitario 12 de Octubre, Madrid, Spain, ²Health Sciences School, Universidad Camilo José Cela, Villanueva de la Cañada, Spain, ³Rheumatology, HOSPITAL UNIVERSITARIO 12 DE OCTUBRE, Madrid, Spain, ⁴Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School, London, United Kingdom, ⁵Rheumatology, Paris Descartes University, Rheumatology A department, Cochin Hospital, Paris, France, ⁶Rheumatology, Universitäts-Poliklinik, Felix-Platter Spital, Basel, Switzerland, ⁷Department of Biomedicine & Division of Rheumatology AOUC, University of Florence, Florence, Italy, ⁸Abt. f. Rheumatologie u. klinische Immunologie, Osteologie, Physikalische Therapie, Kerckhoff-Klinik GmbH, Bad Nauheim, Germany, ⁹Florence
Background/Purpose: to identify risk factors for early mortality in a large group of recently diagnosed systemic sclerosis (SSc) patients Methods: EUSTAR collects prospectively the Minimal…
Abstract Number: 728 • 2012 ACR/ARHP Annual Meeting
Does the Use of Angiotensin Converting Enzyme Inhibitors Prior to Scleroderma Renal Crisis Affect Prognosis ? – Results of the International Scleroderma Renal Crisis Survey
Marie Hudson¹, Murray Baron², Solene Tatibouet¹, Daniel Furst³, Dinesh Khanna⁴ and International Scleroderma Renal Crisis Study Investigaots⁵, ¹Jewish General Hospital, McGill University, Montreal, QC, Canada, ²Pavillion A, Rm 216, Lady David Institute for Medical Research and Jewish General Hospital, Montreal, QC, Canada, ³David Geffen School of Medicine, Div of Rheumatology, University of California at Los Angeles, Los Angeles, CA, ⁴Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI, ⁵Montreal
Background/Purpose: Scleroderma renal crisis (SRC) is an infrequent but life-threatening complication of systemic sclerosis (SSc). The outcome of SRC has improved considerably since the advent…
Abstract Number: 724 • 2012 ACR/ARHP Annual Meeting
Survival, Hospitalization or Need for Combination Therapy At One Year in Patients with Scleroderma-Associated Pulmonary Arterial Hypertension
Robyn T. Domsic¹, Lorinda Chung², Jessica K. Gordon³, Yona Cloonan⁴, Virginia D. Steen⁵ and PHAROS Investigators⁶, ¹Medicine - Rheumatology, University of Pittsburgh, Pittsburgh, PA, ²Rheumatology, Stanford Univ Medical Center, Palo Alto, CA, ³Rheumatology, Hospital for Special Surgery, New York, NY, ⁴Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, ⁵Department of Rheumatology, Georgetown University Medical Center, Washington, DC, ⁶Washington, DC, DC
Background/Purpose: Pulmonary arterial hypertension (PAH) is a leading cause of death in patients with systemic sclerosis (SSc). Although survival has improved with PAH-specific medications in…
Abstract Number: 936 • 2012 ACR/ARHP Annual Meeting
Autoimmune Diseases: Declining Mortality Between 1999 and 2008 However Continuing to be a Leading Cause of Death in Children-A 10-Year Retrospective Review
Eric Y. Yen¹ and Deborah K. McCurdy², ¹Pediatrics/Rheumatology, UCLA Division of Pediatric Rheumatology, Los Angeles, CA, ²Pediatric Rheumatology, UCLA Division of Pediatric Rheumatology, Los Angeles, CA
Background/Purpose: Autoimmune diseases are chronic illnesses that cause significant and chronic disability in children and may lead to death. Using mortality data from 1995, Walsh…
Abstract Number: 1410 • 2012 ACR/ARHP Annual Meeting
Relationship Between Individual Organ Damage and Mortality of Systemic Lupus Erythematosus (SLE): A Prospective Cohort Study of 679 Patients
Chi Chiu Mok, Ling Yin Ho and Ka Lung Yu, Medicine, Tuen Mun Hospital, Hong Kong, Hong Kong
Background/Purpose: To study the relationship between damage in different organ systems and mortality in patients with SLE. Methods: 679 patients who fulfilled at least 4…
Abstract Number: 1407 • 2012 ACR/ARHP Annual Meeting
The Effect of the Antiphospholipid Syndrome (APS) On Survival in Chinese Patients with SLE: A Prospective Study of 679 Patients
Chi Chiu Mok, Ling Yin Ho, Ka Lung Yu and Chi Hung To, Medicine, Tuen Mun Hospital, Hong Kong, Hong Kong
Background/Purpose: To study the effect of the antiphospholipid syndrome (APS) on survival in Chinese patients with SLE Methods: A cohort of 679 southern Chinese patients…
Abstract Number: 1665 • 2012 ACR/ARHP Annual Meeting
Associations of Race and Ethnicity with Overall Mortality and Cardiovascular Events Among Patients with End-Stage Renal Disease Due to Lupus Nephritis
Jose A. Gomez-Puerta¹, Sushrut Waikar², Graciela S. Alarcon³, Jun Liu⁴, Daniel H. Solomon⁵, Wolfgang C. Winkelmayer⁶ and Karen H. Costenbader⁷, ¹Section of Clinical Sciences, Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, Boston, MA, ²Division of Nephrology, Brigham and Women's Hospital, Harvard Medical School, Boston, Boston, MA, ³Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, ⁴Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, Boston, MA, ⁵Division of Rheumatology, Brigham and Women's Hospital, Boston, MA, ⁶Division of Nephrology, Stanford University School of Medicine, Stanford, CA, ⁷Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
Background/Purpose: Patients with SLE and lupus nephritis (LN) are at elevated risks of cardiovascular disease. Past studies have suggested that African American patients with SLE…
Abstract Number: 2044 • 2012 ACR/ARHP Annual Meeting
Trying to Improve Care: A Review of the Morbidity and Mortality Conference in the Division of Rheumotology
Michelle Batthish¹, Shirley Tse², Brian M. Feldman³, G. Ross Baker⁴ and Ronald Laxer⁵, ¹Pediatric Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, ²Rheumatology, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada, ³Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, ⁴Institute of Health Policy, Management and Evaluation, The University of Toronto, Toronto, ON, Canada, ⁵Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada
Background/Purpose: The morbidity and mortality conference (M&MC) is one of academic medicine’s most visible fora for discussion of adverse events and errors; however it is…
Abstract Number: 2559 • 2012 ACR/ARHP Annual Meeting
Mortality in Patients with Psoriatic Arthritis Compared to Patients with Rheumatoid Arthritis, Psoriasis Alone, and the General Population
Alexis Ogdie¹, Kevin Haynes², Andrea Troxel², Thorvardur Love³, Hyon K. Choi⁴ and Joel Gelfand⁵, ¹Rheumatology and Epidemiology, University of Pennsylvania, Philadelphia, PA, ²Clinical Epidemiology and Biostatistics, University of Pennsylvania., Philadelphia, PA, ³Landspitali University Hospital, Reykjavik, Iceland, ⁴Section of Rheumatology and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, ⁵University of Pennsylvania., Philadelphia, PA
Background/Purpose: Conflicting reports of the mortality risk among patients with psoriatic arthritis (PsA) exist in the literature, however excess mortality has been presumed given the…